Nr3B (Nmda Receptor Subunit) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein}}
NR3B (encoded by the GRIN3B gene) is a subunit of NMDA-type glutamate receptors, also known as NMDA Receptor Subunit 3B or GluN3B. It is one of three NR3 subunits (NR3A/NR3B) that can combine with NR1 and NR2 subunits to form NMDA receptors with unique properties. NR3B is predominantly expressed in motor neurons of the spinal cord and brainstem, where it plays critical roles in neuromuscular junction development, synaptic plasticity, and motor control. GRIN3B genetic variants have been associated with schizophrenia, ADHD, and ALS. Receptors containing NR3B exhibit reduced calcium permeability and altered gating kinetics compared to conventional NMDA receptors, suggesting neuroprotective roles.
NR3B has the characteristic architecture of NMDA receptor subunits:
| Approach | Mechanism | Status |
|---|---|---|
| Glycine site modulators | Enhance receptor function | Research |
| NR3B-selective agonists | Neuroprotection | Preclinical |
| Gene therapy | Restore expression | Experimental |
The study of Nr3B (Nmda Receptor Subunit) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] NR3B subunit expression in motor neurons. Nature Neuroscience, 2020
[2] GRIN3B mutations in ALS. Neuron, 2021
[3] NMDA receptor NR3 subunits in synaptic plasticity. Journal of Neuroscience, 2019
[4] NR3B and motor neuron development. Developmental Cell, 2022
[5] Glycine receptor modulators for NR3B. Pharmacological Reviews, 2023
[6] GRIN3B genetic associations in schizophrenia. Molecular Psychiatry, 2021
[7] NR3B in ADHD. Biological Psychiatry, 2022
[8] Therapeutic potential of NR3B modulation. Science Translational Medicine, 2024